ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner

Jaw Ji Yang, Yi Ju Lee, Hsin Hung Hung, Wei Pu Tseng, Chuan Chou Tu, Huei Lee, Wen Jun Wu

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)


Novel mixed-lineage kinase protein zipper sterile-α-motif kinase (ZAK) was first cloned by our laboratory. Lung cancer is the leading cause of cancer-related death in the world, including in Taiwan. Here, we wanted to investigate whether ZAK plays a potential role in lung cancer development. First, Western blot analysis results demonstrated that four cell lines expressed high levels of ZAK from among a panel of 10 lung cancer cell lines, and two of three normal lung cells expressed ZAK. ZAK gene expressions were down-regulated in lung cancers by real-time PCR analysis. Overexpression of ZAK suppressed cell proliferation in parallel with increased phosphorylated levels of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK). In contrast, ZAK silencing cells inhibited the expressions of phosphorylated ERK and JNK without affecting the expression of phosphorylated p38. The effect of the decreased cell growth rate was significantly but incompletely reversed when ZAK-overexpressing cells were treated with a specific ERK or JNK inhibitor. Moreover, c-Fos and c-Jun, the major downstream components of MAPKs, were up-regulated by ERK and JNK, respectively. When ZAK-overexpressing cells introduced with c-Jun RNA interference (RNAi), the activator protein-1 (AP-1) transcription activity detected by a secreted alkaline phosphatase (SEAP) assay was suppressed and the decreased cell number was reversed compared with the control RNAi-treated group. More importantly, ZAK significantly depressed tumor growth in in vivo study. Taken together, results from both in vitro and in vivo studies indicated that the decrease of lung cancer cell proliferation by ZAK may involve the ERK and JNK pathways via an AP-1 transcription factor. (Cancer Sci 2010).

Original languageEnglish
Pages (from-to)1374-1381
Number of pages8
JournalCancer Science
Issue number6
Publication statusPublished - Jun 2010
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner'. Together they form a unique fingerprint.

Cite this